Cargando…
Generation of Leukaemia-Derived Dendritic Cells (DC(leu)) to Improve Anti-Leukaemic Activity in AML: Selection of the Most Efficient Response Modifier Combinations
Dendritic cells (DC) and leukaemia derived DC (DC(leu)) are potent stimulators of anti-leukaemic activity in acute myeloid leukaemia (AML) and can be generated from mononuclear cells in vitro following standard DC/DC(leu)-generating protocols. With respect to future clinical applications though, DC/...
Autores principales: | Schwepcke, Christoph, Klauer, Lara Kristina, Deen, Diana, Amberger, Daniel Christoph, Fischer, Zuzana, Doraneh-Gard, Fatemeh, Gunsilius, Carina, Hirn-Lopez, Annika, Kroell, Tanja, Tischer, Johanna, Weinmann, Melanie, Werner, Jan-Ole, Rank, Andreas, Schmid, Christoph, Schmetzer, Helga Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368668/ https://www.ncbi.nlm.nih.gov/pubmed/35955486 http://dx.doi.org/10.3390/ijms23158333 |
Ejemplares similares
-
P19. Immunomodulation of blasts in AML-patients (pts) with clinically approved response modifiers to improve anti leukaemic T-cell reactivity: an ex vivo simulation of the clinical situation
por: Schmetzer, H, et al.
Publicado: (2014) -
Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes
por: Rackl, Elias, et al.
Publicado: (2022) -
PGE(1)-Containing Protocols Generate Mature (Leukemia-Derived) Dendritic Cells Directly from Leukemic Whole Blood
por: Amberger, Daniel Christoph, et al.
Publicado: (2019) -
Volatile Phases Derived from Serum, DC, or MLC Culture Supernatants to Deduce a VOC-Based Diagnostic Profiling Strategy for Leukemic Diseases
por: Baudrexler, Tobias, et al.
Publicado: (2023) -
Isolated CNS leukaemic relapse in acute myeloid leukaemia
por: Essa, Amr, et al.
Publicado: (2019)